Multimodality in Oncology: Are We There Yet?

Sponsored by SOPHiA GENETICS

Multimodal cancer care is no longer a concept: it’s becoming a reality.

In this thought leadership podcast episode, leading experts from clinical oncology and health technology take a clear-eyed look at where multimodality truly stands today. While widely recognized as the future of oncology, its translation into everyday clinical practice remains uneven and complex.

Hosted by Philippe Menu, MD, PhD, MBA, EVP, Chief Product Officer and Chief Medical Officer at SOPHiA GENETICS, this discussion brings together:

• Pedram Razavi, MD, PhD, Breast Medical Oncologist and Director of the Liquid Biopsy and Cancer Genomics, MSK Biomarker Development Program at Memorial Sloan Kettering Cancer Center (MSKCC), offers a clinician’s view on multimodality, workflow realities, and decision-making at a top cancer center.
• Matthew Lungren, MD, MPH, a professor of clinical AI at Stanford University and Health Technology Leader at Microsoft, shares insights on AI innovation, data infrastructure, and large-scale clinical deployment.

In this episode, you will explore:

• What multimodality truly means in day-to-day oncology practice;
• The key bottlenecks slowing the adoption of AI, including workflow friction, trust, data silos and governance;
• Why innovation is progressing faster than its translation into routine care;
• And a realistic three-year outlook on the multimodal and AI capabilities most likely to impact routine oncology care.

Listen to this thoughtful conversation to gain a grounded and clinically relevant perspective on the promise, the reality, and the future of multimodality in oncology.

Disclaimer

© 2026 SOPHiA GENETICS. All rights reserved. The opinions expressed during this podcast episode are those of the speakers and may or may not represent the opinions of SOPHiA GENETICS.

SOPHiA GENETICS products are for research use only, not for diagnostic procedures unless specified otherwise. Some SOPHiA GENETICS products or technologies described in this podcast episode are under development.